Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  (Non Clinical) Developing methods to enable re-irradiation of patients with head and neck cancer


   Faculty of Biology, Medicine and Health

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Prof M Van Herk, Dr Eliana Vasquez Osorio, Prof David Thompson, Dr Matthew Lowe  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

Radiotherapy uses radiation to treat cancer, and is used as part of the treatment of approximately 80% of patients diagnosed with head and neck cancer. Advances in technology have considerably improved the chances of patients surviving their cancer. However, in up to 40% of patients with head and neck cancer, the tumour will come back or a new tumour will appear in the regions already treated. Treatment of these recurrences using radiotherapy is very challenging because delivering extra radiation in regions that have already been irradiated is often associated with strong, and even fatal, side effects. Currently, doctors cannot confidently recommend re-irradiation, primarily because there are no tools to properly account for previous radiation treatments. However, it has been shown that when patients are properly selected, this treatment dramatically improves the chances of survival and can even offer cure (allowing patients to survive years rather than months).

This project will target this unmet need in radiotherapy planning, by developing novel methods to:

 1) map the radiation received in previous treatments to the current anatomy of the patient,

 2) quantify and model the impact of uncertainties of the mapping procedure, and

 3) include these and other uncertainties in re-irradiation planning.

These methods will be implemented in a commercially available treatment planning software to ease translation to clinical practice, and validated in an independent group of head and neck patients. The results from this work will pave the path to dramatically improve access to a potentially curative treatment which could be the last chance for many patients.

This project will benefit from strong collaboration links with other active researchers within the RRR group (Dr Andrew Green and Dr Azadeh Abravan) and head and neck clinicians at the Christie (including Dr James Price and Dr. Andrew McPartlin).

Entry Requirements

Candidates must hold, or be about to obtain, a minimum upper second class undergraduate degree, or the equivalent qualifications gained outside the UK, in a relevant subject. A related master's degree would be an advantage.

How to Apply

To be considered for this project you MUST submit a formal online application form. Details of how to apply are available here (https://www.bmh.manchester.ac.uk/study/research/funded-programmes/mcrc-training-scheme/apply/). For Visa requirements, international candidates must select the full-time study option.

General enquiries can be directed to [Email Address Removed].

Interviews: Week commencing 10 January 2022

Commencement: October 2022

Equality, Diversity and Inclusion

Equality, diversity and inclusion is fundamental to the success of The University of Manchester and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/

Biological Sciences (4)

Funding Notes

Funding will cover UK tuition fees and stipend only (currently at £19,000 per annum). The University of Manchester aims to support the most outstanding applicants from outside the UK. We are able to offer a limited number of scholarships that will enable full studentships to be awarded to international applicants. These full studentships will only be awarded to exceptional quality candidates, due to the competitive nature of this scheme. Funding is available for four years full-time, or pro rata for part-time study. Part-time awards cannot be less than 50% of full time.

References

1 Pulte, D. et al. Oncologist 15, 994 (2010)
2 Strojan, P. et al. Cancer Treatment Reviews 59, 79–92 (2017)
3 Ho, J. C. et al. Head Neck 40, 2078–2093 (2018)
4 Embring, A. et al. Radiat. Oncol. 2020 151 15, 1–10 (2020)
5 Kim, Y. S. Radiat. Oncol. J. 35, 1–15 (2017)
6 Vásquez Osorio, E. M. et al. Int. J. Radiat. Oncol. Biol. Phys. 80, (2011)
7 Rigaud, B. et al. https://doi.org/10.1080/0284186X.2019.1620331 58, 1225–1237 (2019)
8 Zhong, H. et al. Int. J. Radiat. Oncol. Biol. Phys. 97, 182–183 (2017)
9 Vásquez Osorio, E. M. et al. Med. Phys. 42, 206–220 (2015)
10 Saleh-Sayah, N. K. et al. Med. Phys. 38, 2318–2323 (2011)
11 Vasquez Osorio, E. M. et al. Radiother. Oncol. 115, S119–S120 (2015)
12 Murray, L. et al. Radiother. Oncol. 152, S50 (2020)